Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will assess the feasibility and usability of COVID-19 professional and self-administered Antigen-Rapid Diagnostic Tests (Ag-RDTs) through health facility outpatient services and community settings in Kampala and Luwero districts in Uganda.
There are two components to this study:
Key outcomes target the implementation's success, demand, and usability of professional and self-administered Ag-RDTs.
This study seeks to understand the feasibility and usability of COVID-19 Ag-RDT self-tests among Boda boda drivers and FSWs in community-based settings in two districts of Uganda. Ag-RDT COVID-19 professional use tests will also be assessed, among patients soliciting OPD services in health facilities, to support public-sector screening when qRT-PCR testing services are limited or unavailable. Feasibility for the purposes of this intervention refers to core factors affecting implementation success (i.e., barriers, facilitators, user preferences, and acceptability of Ag-RDT use and implementation) and demand (the measure of actual use of professional and self-administered Ag-RDTs in the population). Usability is defined as the extent to which FSWs, Boda boda drivers, and OPD patients, and household contacts of OPD patients self-report their comfort with performing critical self-testing procedures (sample collection, sample processing, and results interpretation) autonomously.
Primary Research Objective
• To assess the feasibility of using professional and self-administered COVID-19 Ag-RDTs in facility OPD and community settings in Uganda.
Secondary Research Objective • Determine usability of Ag-RDT COVID-19 self-tests among FSWs, Boda boda drivers, OPD patients, and household contacts of OPD patients.
Primary outcomes: Feasibility of professional and self-administered COVID-19 Ag-RDT use.
Secondary outcomes: Usability of Ag-RDT self-administered tests.
• Usability. Proportion of assisted self-testers compared to unassisted self-testers who self-report that they feel comfortable using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Facility-based Ag-RDT COVID-19 testing - reactive | Experimental | Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with reactive test result |
|
| Facility-based Ag-RDT COVID-19 testing - non-reactive | Experimental | Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with non-reactive test result |
|
| COVID-19 Ag-RDT self-testing - agree to self-test | Experimental | Participants who receive and take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts) |
|
| COVID-19 Ag-RDT self-testing - refuse to self-test | No Intervention | Participants who receive but refuse to take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PMC Sure Status COVID-19 Antigen Test | Diagnostic Test | COVID-19 professional use kit in out-patient departments |
|
| Measure | Description | Time Frame |
|---|---|---|
| Implementation success | Proportion of focus group discussion responses on the barriers, facilitators, user preferences, and acceptability to offering COVID-19 Ag-RDT professional and self-administered kits in health facilities and community settings through thematic analysis. | 6 months |
| Demand - OPD | Proportion of COVID-19 OPD cases identified via professional use testing who accept self-testing kits for their contacts. | 6 months |
| Demand - Community | Proportion of FSWs, Boda boda drivers, and household contacts who use Ag-RDT COVID-19 self-tests and report their results. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Usability | Proportion of assisted self-testers compared to unassisted self-testers who self-report their comfort with correctly using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers). | 6 months |
Not provided
OPD patients (index cases) for professional use testing
Inclusion Criteria:
Exclusion Criteria:
Household contacts of OPD patients for self-testing
Inclusion Criteria:
Exclusion Criteria
Community-based self-testing participants (FSWs and Boda boda drivers)
Inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kimberly Green | PATH | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kisenyi Health Center IV | Kampala | Central Region | 7404 | Uganda | ||
| Kiswa Health Center III |
The investigators do not plan to share any individual participant data, as study data will be aggregated into the study database for analysis and further dissemination of results.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Acon Flowflex COVID-19 Antigen Home Test | Diagnostic Test | COVID-19 self-test kits |
|
| Kampala |
| Central Region |
| 7404 |
| Uganda |
| Katikamu Health Center III | Luwero | Central Region | 7404 | Uganda |
| Luwero Hospital | Luwero | Central Region | 7404 | Uganda |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |